image of Amit J. Sabnis
  • Telehealth Visits
bch logo

Amit J. Sabnis, MD, MS

Hematology and Medical Oncology • Medical Oncology
image of Amit J. Sabnis
image of Amit J. Sabnis
bch logo

Amit J. Sabnis, MD, MS

Hematology and Medical Oncology • Medical Oncology
  • Telehealth Visits

On this page

About me

Dr. Amit J. Sabnis is a hematologist-oncologist who cares for children with sarcomas, cancers of connective tissue that are more common in pediatric patients than adults.

In research, Sabnis uses genetic and biochemical tools to understand how sarcomas exploit normal cellular controls to allow abnormal rates of protein synthesis; the goal is to identify targets for new, selective drugs. He also collaborates closely with colleagues to turn laboratory findings into first-in-children trials measuring the safety and efficacy of new cancer therapies.

Sabnis earned a master's degree in biological sciences from Stanford University. At UCSF, he earned his medical degree and completed a residency in pediatrics and a fellowship in pediatric hematology and oncology, as well as additional training in biomedical research.

Education

Board Certification

  • Pediatric Hematology-Oncology, American Board of Pediatrics
  • Pediatrics, American Board of Pediatrics

Fellowship

  • Oncology, UCSF School of Medicine -GME

Residency

  • Pediatrics, UCSF Medical Center House Staff

Internship

  • Pediatrics, UCSF Medical Center House Staff

School

  • MD, UCSF School of Medicine

Academic Title

  • Clinical Professor

Care Keywords

  • Services
    • Hematology and Medical Oncology
    • Medical Oncology
    • Pediatric Hematology-Oncology

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.